New Phase 2 Data for Somapacitan Demonstrate Its Potential as an Efficacious Once-weekly Treatment for Childhood Growth Hormone Deficiency

Somapacitan, a novel growth hormone derivative in development for once-weekly administration of growth hormone, matched the therapeutic benefits of once-daily Norditropin® (somatropin) in a phase...

Protein Expression Market to be Driven by Rising Protein and Biologics Production Till 2025 | Million Insights

The global Protein Expression Market is anticipated to grow at a CAGR of 10.4% by 2025 and is expected to cross USD 3.0 billion in the forecast period. Protein expression could prove to be a complex process,...

Ozempic® Consistently Reduced the Risk of Major Cardiovascular Events Across Type 2 Diabetes Populations at High CV Risk Regardless of Prior CV Events at Baseline

‘Cardiovascular disease remains the leading cause of disability and death in people with type 2 diabetes and there is an increasing focus on reducing cardiovascular risk in the clinic,’ said...

Q Biomed Inc. Extends its Exclusive Option Agreement With Washington University in St. Louis for a Novel Companion Biomarker for Monitoring Glaucoma and Initiates a Clinical Study

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration development company, is pleased to announce that it is extending its option agreement with Washington University in St. Louis....

Q BioMed Inc. Provides Important Update on Mannin Research Tie2 Technology Platform Development

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration development company, provides the following update on its exclusively licensed platform technology asset from Mannin Research...

PharmaMar Announces Participation at the 17th Needham & Co Annual Healthcare Conference in New York City

PharmaMar (MCE: PHM), today announced it will be featured as a presenting company at the 17th Needham & Co Annual Healthcare Conference. The conference is being held on March 27-28 at the Westin...

Utilizzando il sito, accetti l'utilizzo dei cookie da parte nostra. maggiori informazioni

Questo sito utilizza i cookie per fornire la migliore esperienza di navigazione possibile. Continuando a utilizzare questo sito senza modificare le impostazioni dei cookie o cliccando su "Accetta" permetti il loro utilizzo.

Chiudi